Search Results - "Hohe, R"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Low density lipoproteins inhibit endotoxin activation of monocytes by Weinstock, C, Ullrich, H, Hohe, R, Berg, A, Baumstark, M W, Frey, I, Northoff, H, Flegel, W A

    Published in Arteriosclerosis and thrombosis (01-03-1992)
    “…Human serum and low density lipoproteins (LDLs) were shown to inactivate endotoxin (lipopolysaccharide [LPS]) by testing the effect of LPS interactions with…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5

    Raman microscopic investigations of BaTiO3 precursors with core?shell structure by Rossel, M, Hoche, H-R, Leipner, H S, Voltzke, D, Abicht, H-P, Hollricher, O, Muller, J, Gablenz, S

    Published in Analytical and bioanalytical chemistry (01-09-2004)
    “…Due to their outstanding dielectric and ferroelectric properties, barium titanate (BaTiO3)-based ceramics have found many applications in electronic devices…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Rheologic studies before and after therapeutic cytapheresis and plasma exchange treatment by Waxenberger, Y, Schäd, S, Gross, D, Ullrich, H, Hohe, R, Langer, R, Henrich, H, Weibecke, D

    “…Changes in rheological properties of human blood before and after platelet pheresis were measured in patients with myeloproliferative diseases as well as in a…”
    Get more information
    Journal Article
  9. 9

    Therapeutic thrombocytapheresis in patients with myeloproliferative diseases with the cell separators Fresenius AS 104 and Cobe Spectra: biocompatibility and safety by Ullrich, H, Kadar, J, Waxenberger, Y, Hohe, R, Saueressig, C, Heyder, M, Wiebecke, D

    “…We studied biocompatibility, safety and efficiency of the two cell separators AS 104 (Fresenius) and Spectra (Cobe) during therapeutic thrombocytaphereses…”
    Get more information
    Journal Article
  10. 10